Plant-derived monoclonal antibodies as human biologics for infectious disease and cancer

Plant-derived Pharmaceuticals: Principles and Applications for Developing Countries

Volumn , Issue , 2014, Pages 42-75

  Chen, Qiang ^a   Lai, Huafang ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927961289     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (91)

1. Alexopoulou, L., Holt, A.C., Medzhitov, R. and Flavell, R.A. (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413(6857), 732-738.
2. Barta, A., Sommergruber, K., Thompson, D., Hartmuth, K., Matzke, M.A. and Matzke, A.J.M. (1986) The expression of a nopaline synthase - human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue. Plant Molecular Biology 6(5), 347-357.
3. Bendandi, M. (2006) Clinical benefit of idiotype vaccines: too many trials for a clever demonstration? Reviews of Recent Clinical Trials 1(1), 67-74.
4. Bendandi, M., Marillonnet, S., Kandzia, R., Thieme, F., Nickstadt, A., Herz, S., Frode, R., Inoges, S., Lopez-Diaz de Cerio, A., Soria, E., Villanueva, H., Vancanneyt, G., McCormick, A., Tuse, D., Lenz, J., Butler-Ransohoff, J.E., Klimyuk, V. and Gleba, Y. (2010) Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Annals of Oncology 21(12), 2420-2427.
5. Bente, D., Gren, J., Strong, J.E. and Feldmann, H. (2009) Disease modeling for Ebola and Marburg viruses. Disease Models & Mechanisms 2(1-2), 12-17.
6. Bode, A.V., Sejvar, J.J., Pape, W.J., Campbell, G.L. and Marfin, A.A. (2006) West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clinical Infectious Diseases 42(9), 1234-1240.
7. Bosch, D., Castilho, A., Loos, A., Schots, A. and Steinkellner, H. (2013) N-Glycosylation of Plant-produced Recombinant Proteins. Current Pharmaceutical Design 19(31), 5503-5512.
8. Brisson, N., Paszkowski, J., Penswick, J., Bronenborn, B., Potrykus, I. and Hohn, T. (1984) Expression of a bacterial gene in plants by using a viral vector. Nature 310, 511-514.
9. Castilho, A., Strasser, R., Stadlmann, J., Grass, J., Jez, J., Gattinger, P., Kunert, R., Quendler, H., Pabst, M., Leonard, R., Altmann, F. and Steinkellner, H. (2010) In planta protein sialylation through overexpression of the respective mammalian pathway. Journal of Biological Chemistry 285(21), 15923-15930.
10. Chargelegue, D., Vine, N.D., van Dolleweerd, C.J., Drake, P.M. and Ma, J.K. (2000) A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. Transgenic Research 9(3), 187-194.
11. Chargelegue, D., Drake, P.M.W., Obregon, P., Prada, A., Fairweather, N. and Ma, J.K.C. (2005) Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants. Infection and Immunity 73(9), 5915-5922.
12. Chen, Q. (2008) Expression and Purification of Pharmaceutical Proteins in Plants. Biological Engineering 1(4), 291-321.
13. Chen, Q. (2011a) Expression and manufacture of pharmaceutical proteins in genetically engineered horticultural plants. In: Mou, B. and Scorza, R. (eds) Transgenic Horticultural Crops: Challenges and Opportunities - Essays by Experts. Taylor & Francis, Boca Raton, Florida, pp. 83-124.
14. Chen, Q. (2011b) Turning a new leaf. European Biopharmaceutical Review 2(56), 64-68.
15. Chen, Q. and Lai, H. (2013) Plant-derived virus-like particles as vaccines. Human Vaccines & Immunotherapeutics 9(1), 26-49.
16. Chen, Q., Mason, H., Mor, T., Cardineau, G.A., Arntzen, C. and Tacket, C.O. (2009) Subunit vaccines produced using plant biotechnology. In: Levine, M.M. (ed.) New Generation Vaccines. Informa Healthcare, New York, pp. 306-315.
17. Chen, Q., He, J., Phoolcharoen, W. and Mason, H.S. (2011) Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants. Human Vaccines 7(3), 331-338.
18. Chen, Q., Lai, H., Hurtado, J., Stahnke, J., Leuzinger, K. and Dent, M. (2013) Agroinfiltration as an Effective and Scalable Strategy of Gene Delivery for Production of Pharmaceutical Proteins. Advanced Techniques in Biology and Medicine 1(1), 9.
19. Daniell, H. (2006) Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnology Journal 1(10), 1071-1079.
20. Diamond, M.S. and Klein, R.S. (2006) A genetic basis for human susceptibility to West Nile virus. Trends in Microbiology 14(7), 287-289.
21. Dietrich, C. and Maiss, E. (2003) Fluorescent labelling reveals spatial separation of potyvirus populations in mixed infected Nicotiana benthamiana plants. Journal of General Virology 84(10), 2871-2876.
22. Dugdale, B., Mortimer, C.L., Kato, M., James, T.A., Harding, R.M. and Dale, J.L. (2013) In Plant Activation: An Inducible, Hyperexpression Platform for Recombinant Protein Production in Plants. The Plant Cell Online 25(7), 2429-2443.
23. Duke, J. (1993) Medicinal plants and the pharmaceutical industry. In: Janick, J. and Simon, J. (eds) New crops. Wiley, New York, pp. 664-669.
24. Ellis, D.S., Simpson, I.H., Francis, D.P., Knobloch, J., Bowen, E.T., Lolik, P. and Deng, I.M. (1978) Ultrastructure of Ebola virus particles in human liver. Journal of Clinical Pathology 31(3), 201-208.
25. Farnsworth, N.R., Akerele, O., Bingel, A.S., Soejarto, D.D. and Guo, Z. (1985) Medicinal plants in therapy. Bulletin of the World Health Organisation 63(6), 965-981.
26. Faye, L. and Gomord, V. (2010) Success stories in molecular farming - a brief overview. Plant Biotechnology Journal 8(5), 525-528.
27. Geisbert, T.W., Geisbert, J.B., Leung, A., Daddario-DiCaprio, K.M., Hensley, L.E., Grolla, A. and Feldmann, H. (2009) Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus. Journal of Virology 83(14), 7296-7304.
28. Giritch, A., Marillonnet, S., Engler, C., van Eldik, G., Botterman, J., Klimyuk, V. and Gleba, Y. (2006) Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proceedings of the National Academy of Sciences USA 103(40), 14701-14706.
29. Gomord, V., Fitchette, A.C., Menu-Bouaouiche, L., Saint-Jore-Dupas, C., Plasson, C., Michaud, D. and Faye, L. (2010) Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnology Journal 8(5), 564-587.
30. Harrison, R.L. and Jarvis, D.L. (2006) Protein N-Glycosylation in the Baculovirus-Insect Cell Expression System and Engineering of Insect Cells to Produce 'Mammalianized' Recombinant Glycoproteins. Advances in Virus Research, Vol. 68. Academic Press, Waltham, Massachusetts, pp. 159-191.
31. He, J., Lai, H., Brock, C. and Chen, Q. (2012) A novel system for rapid and cost-effective production of detection and diagnostic reagents of West Nile virus in plants. Journal of Biomedicine and Biotechnology 2012 (10.1155/2012/106783), 1-10.
32. He, J., Lai, H., Engle, M., Gorlatov, S., Gruber, C., Steinkellner, H., Diamond, M. and Chen, Q. (2014a) Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus. PLoS ONE 9(3), e93541.
33. He, J., Peng, L., Lai, H., Hurtado, J., Stahnke, J. and Chen, Q. (2014b) A plant-produced antigen elicits potent immune responses against West Nile virus in mice. BioMed Research Inter national 2014(10.1155/2014/952865), 10.
34. Hiatt, A. and Pauly, M. (2006) Monoclonal antibodies from plants: a new speed record. Proceedings of the National Academy of Sciences USA 103(40), 14645-14646.
35. Hiatt, A., Cafferkey, R. and Bowdish, K. (1989) Production of antibodies in transgenic plants. Nature 342(6245), 76-78.
36. Hossler, P., Khattak, S.F. and Li, Z.J. (2009) Optimal and consistent protein glycosylation in mam malian cell culture. Glycobiology 19(9), 936-949.
37. Huang, Z., Chen, Q., Hjelm, B., Arntzen, C. and Mason, H. (2009) A DNA replicon system for rapid highlevel production of virus-like particles in plants. Biotechnology and Bioengineering 103(4), 706-714.
38. Huang, Z., Phoolcharoen, W., Lai, H., Piensook, K., Cardineau, G., Zeitlin, L., Whaley, K., Arntzen, C.J., Mason, H. and Chen, Q. (2010) High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnology and Bio engineering 106(1), 9-17.
39. Hubalek, Z. and Halouzka, J. (1999) West Nile fever - a reemerging mosquito-borne viral disease in Europe. Emerging Infectious Diseases 5(5), 643-650.
40. Hull, R. and Plaskitt, A. (1970) Electron microscopy on the behavior of two strains of alfalfa mosaic virus in mixed infections. Virology 42(3), 773-776.
41. Kathuria, S., Sriraman, R., Nath, R., Sack, M., Pal, R., Artsaenko, O., Talwar, G.P., Fischer, R. and Finnern, R. (2002) Efficacy of plant-produced recombinant antibodies against HCG. Human Reproduction 17(8), 2054-2061.
42. Klee, H., Horsch, R. and Rogers, S. (1987) Agrobacterium-mediated plant transformation and its further applications to plant biology. Annual Review of Plant Physiology 38, 467-486.
43. Komarova, T.V., Baschieri, S., Donini, M., Marusic, C., Benvenuto, E. and Dorokhov, Y.L. (2010) Transient expression systems for plant-derived biopharmaceuticals. Expert Review of Vaccines 9(8), 859-876.
44. Komarova, T.V., Kosorukov, V.S., Frolova, O.Y., Petrunia, I.V., Skrypnik, K.A., Gleba, Y.Y. and Dorokhov, Y.L. (2011) Plant-made trastuzumab (herceptin) inhibits HER2/Neu+ cell pro liferation and retards tumor growth. PLoS ONE 6(3), e17541.
45. Lai, H. and Chen, Q. (2012) Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations. Plant Cell Reports 31(3), 573-584.
46. Lai, H., Engle, M., Fuchs, A., Keller, T., Johnson, S., Gorlatov, S., Diamond, M.S. and Chen, Q. (2010) Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice. Proceedings of the National Academy of Sciences USA 107(6), 2419-2424.
47. Lai, H., He, J., Diamond, M.S. and Chen, Q. (2012) Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce. Plant Biotechnology Journal 10( 1), 95-104.
48. Lai, H., He, J., Hurtado, J., Stahnke, J., Fuchs, A., Mehlhop, E., Gorlatov, S., Loos, A., Diamond, M.S. and Chen, Q. (2014) Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants. Plant Biotechnology Journal doi: 10.1111/pbi-12217.
49. Latham, T. and Galarza, J.M. (2001) Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. Journal of Virology 75(13), 6154-6165.
50. Leuzinger, K., Dent, M., Hurtado, J., Stahnke, J., Lai, H., Zhou, X. and Chen, Q. (2013) Efficient agroinfiltration of plants for high-level transient expression of recombinant proteins. Journal of Visualized Experiments (77), doi: 10.3791/50521.
51. Li, H. and da'Anjou, M. (2009) Pharmacological significance of glycosylation in therapeutic proteins. Current Opinion in Biotechnology 20(6), 678-684.
52. Lico, C., Capuano, F., Renzone, G., Donini, M., Marusic, C., Scaloni, A., Benvenuto, E. and Baschieri, S. (2006) Peptide display on Potato virus X: molecular features of the coat protein-fused peptide affecting cell-to-cell and phloem movement of chimeric virus particles. Journal of General Virology 87(10), 3103-3112.
53. Lico, C., Chen, Q. and Santi, L. (2008) Viral vectors for production of recombinant proteins in plants. Journal of Cellular Physiology 216(2), 366-377.
54. Lim, J.K., Louie, C.Y., Glaser, C., Jean, C., Johnson, B., Johnson, H., McDermott, D.H. and Murphy, P.M. (2008) Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. Journal of Infectious Disease 197(2), 262-265.
55. Liu, L., van Tonder, T., Pietersen, G., Davies, J.W. and Stanley, J. (1997) Molecular characterization of a subgroup I geminivirus from a legume in South Africa. Journal of General Virology 78(8), 2113-2117.
56. Ma, J.K., Hikmat, B.Y., Wycoff, K., Vine, N.D., Chargelegue, D., Yu, L., Hein, M.B. and Lehner, T. (1998) Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nature Medicine 4(5), 601-606.
57. Marillonnet, S., Giritch, A., Gils, M., Kandzia, R., Klimyuk, V. and Gleba, Y. (2004) In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proceedings of the National Academy of Sciences USA 101(18), 6852-6857.
58. McCormick, A.A., Kumagai, M.H., Hanley, K., Turpen, T.H., Hakim, I., Grill, L.K., Tuse, D., Levy, S. and Levy, R. (1999) Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. Proceedings of the National Academy of Sciences USA 96(2), 703-708.
59. McCormick, A.A., Reinl, S.J., Cameron, T.I., Vojdani, F., Fronefield, M., Levy, R. and Tuse, D. (2003) Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig. Journal of Immunology Methods 278(1-2), 95-104.
60. McCormick, A.A., Reddy, S., Reinl, S.J., Cameron, T.I., Czerwinkski, D.K., Vojdani, F., Hanley, K.M., Garger, S.J., White, E.L., Novak, J., Barrett, J., Holtz, R.B., Tusac, D. and Levy, R. (2008) Plantproduced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: Safety and immuno genicity in a phase I clinical study. Proceedings of the National Academy of Sciences USA 105(29), 10131-10136.
61. Mullard, A. (2012) Can next-generation antibodies offset biosimilar competition? Nature Reviews - Drug Discovery 11(6), 426-428.
62. Musiychuk, K., Stevenson, N., Bi, H., Farrance, C.E., Orozovic, C., Brodelius, M., Brodelius, P., Horsey, A., Ugulava, N., Shamloul, A.-M., Mett, V., Rabindran, S., Streatfield, S.J. and Yusibov, V. (2007) A launch vector for the production of vaccine antigens in plants. Influenza 1, 19-25.
63. Olinger, G.G., Pettitt, J., Kim, D., Working, C., Bohorov, O., Bratcher, B., Hiatt, E., Hume, S.D., Johnson, A.K., Morton, J., Pauly, M., Whaley, K.J., Lear, C.M., Biggins, J.E., Scully, C., Hensley, L. and Zeitlin, L. (2012) Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proceedings of the National Academy of Sciences USA 109(44), 18030-18045.
64. Panella, N.A., Burkhalter, K.L., Langevin, S.A., Brault, A.C., Schooley, L.M., Biggerstaff, B.J., Nasci, R.S. and Komar, N. (2005) Rapid West Nile virus antigen detection. Emerging Infectious Disease 11(10), 1633-1635.
65. Peeters, K., De Wilde, C. and Depicker, A. (2001) Highly efficient targeting and accumulation of a Fab fragment within the secretory pathway and apoplast of Arabidopsis thaliana. European Journal of Biochemistry 268(15), 4251-4260.
66. Phoolcharoen, W., Bhoo, S.H., Lai, H., Ma, J., Arntzen, C.J., Chen, Q. and Mason, H.S. (2011a) Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana. Plant Biotechnology Journal 9(7), 807-816.
67. Phoolcharoen, W., Dye, J.M., Kilbourne, J., Piensook, K., Pratt, W.D., Arntzen, C.J., Chen, Q., Mason, H.S. and Herbst-Kralovetz, M.M. (2011b) A nonreplicating subunit vaccine pro tects mice against lethal Ebola virus challenge. Proceedings of the National Academy of Sciences USA 108(51), 20695-20700.
68. Platis, D. and Labrou, N.E. (2008) Affinity chromatography for the purification of thera peutic proteins from transgenic maize using immobilized histamine. Journal of Separation Science 31(4), 636-645.
69. Pogue, G., Vojdani, F., Palmer, K.C., Hiatt, E., Hume, S., Phelps, J., Long, L., Bohorova, N., Kim, D., Pauly, M., Velasco, J., Whaley, K., Zeitlin, L., Garger, S., White, E., Bai, Y., Haydon, H. and Bratcher, B. (2010) Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotechnology Journal 8(5), 638-654.
70. Porta, C., Spall, V.E., Findlay, K.C., Gergerich, R.C., Farrance, C.E. and Lomonossoff, G.P. (2003) Cowpea mosaic virus-based chimaeras. Effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses. Virology 310(1), 50-63.
71. Pushko, P., Bray, M., Ludwig, G.V., Parker, M., Schmaljohn, A., Sanchez, A., Jahrling, P.B. and Smith, J.F. (2000) Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine 19(1), 142-153.
72. Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P. and Amigorena, S. (1999) Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. Journal of Experimental Medicine 189(2), 371-380.
73. Richardson, J. S., Yao, M.K., Tran, K.N., Croyle, M.A., Strong, J.E., Feldmann, H. and Kobinger, G.P. (2009) Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine. PLoS ONE 4(4), e5308.
74. Rivera, A., Gomez-Lim, M., Fernandez, F. and Loske, A. (2012) Physical methods for genetic plant transformation. Physics of Life Reviews 9(3), 308-345.
75. Roque, A.C.A., Lowe, C.R. and Taipa, M.A. (2004) Antibodies and genetically engineered related molecules: production and purification. Bio technology Progress 20(3), 639-654.
76. Sainsbury, F. and Lomonossoff, G.P. (2008) Extremely high-level and rapid transient protein production in plants without the use of viral replication. Plant Physiology 148(3), 1212-1218.
77. Sainsbury, F., Sack, M., Stadlmann, J., Quendler, H., Fischer, R. and Lomonossoff, G.P. (2010) Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody. PLoS ONE 5(11), e13976.
78. Samuel, M.A., Wang, H., Siddharthan, V., Morrey, J.D. and Diamond, M.S. (2007) Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proceedings of the National Academy of Sciences USA 104(43), 17140-17145.
79. Sanford, J.C. (1990) Biolistic plant transformation. Physiologia Plantarum 79(1), 206-209.
80. Santi, L., Batchelor, L., Huang, Z., Hjelm, B., Kilbourne, J., Arntzen, C.J., Chen, Q. and Mason, H.S. (2008) An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 26(15), 1846-1854.
81. Scholthof, H.B., Morris, T.J. and Jackson, A.O. (1993) The capsid protein gene of tomato bushy stunt virus is dispensable for systemic movement and can be replaced for localized expression of foreign genes. Molecular Plant-Microbe Interactions 6, 309-322.
82. Strasser, R., Stadlmann, J., Schahs, M., Stiegler, G., Quendler, H., Mach, L., Glössl, J., Weterings, K., Pabst, M. and Steinkellner, H. (2008) Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnology Journal 6(4), 392-402.
83. Strasser, R., Castilho, A., Stadlmann, J., Kunert, R., Quendler, H., Gattinger, P., Jez, J., Rademacher, T., Altmann, F., Mach, L. and Steinkellner, H. (2009) Improved virus neutralization by plant-produced anti-HIV antibodies with a homo geneous b1,4-galactosylated N-glycan profile. Journal of Biological Chemistry 284(31), 20479-20485.
84. Thuenemann, E.C., Meyers, A.E., Verwey, J., Rybicki, E.P. and Lomonossoff, G.P. (2013) A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles. Plant Biotechnology Journal 11(7), 839-846.
85. Umana, P., Jean-Mairet, J., Moudry, R., Amstutz, H. and Bailey, J.E. (1999) Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nature Biotechnology 17(2), 176-180.
86. Whaley, K., Morton, J., Hume, S., Hiatt, E., Bratcher, B., Klimyuk, V., Hiatt, A., Pauly, M. and Zeitlin, L. (2012) Emerging Antibody-based Products. Springer, Berlin, Heidelberg, pp. 1-20.
87. Wilson, J.A., Hevey, M., Bakken, R., Guest, S., Bray, M., Schmaljohn, A.L. and Hart, M.K. (2000) Epitopes involved in antibody-mediated protection from Ebola virus. Science 287(5458), 1664-1666.
88. Wilson, J.A., Bosio, C.M. and Hart, M.K. (2001) Ebola virus: the search for vaccines and treatments. Cellular and Molecular Life Sciences 58(12-13), 1826-1841.
89. Yin, J., Li, G., Ren, X. and Herrler, G. (2007) Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. Journal of Biotechnology 127(3), 335-347.
90. Zeitlin, L., Pettitt, J., Scully, C., Bohorova, N., Kim, D., Pauly, M., Hiatt, A., Ngo, L., Steinkellner, H., Whaley, K.J. and Olinger, G.G. (2011) Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proceedings of the National Academy of Sciences USA 108(51), 20690-20694.
91. Zeitlin, L., Bohorov, O., Bohorova, N., Hiatt, A., Kim, D.H., Pauly, M.H., Velasco, J., Whaley, K.J., Barnard, D.L., Bates, J.T., Crowe, J.E., Piedra, P.A. and Gilbert, B.E. (2013) Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. mAbs 5(2), 263-269.